Results 251 to 260 of about 6,667,826 (304)

Independent prognostic ımpact of perineural ınvasion in breast cancer patients with residual disease after neoadjuvant chemotherapy. [PDF]

Rev Assoc Med Bras (1992)
Elçiçek ÖF, Yalıcı Ö, Çavdar E, Gedik E, Öznur M, Avcı O, Şeber ES.   +6 more
europepmc   +1 more source

Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia. [PDF]

Blood Cancer J
Bolarinwa A, Yousuf M, Al-Kali A, Alkhateeb HB, Mangaonkar AA, Saliba AN, Hefazi Torghabeh M, Matin A, Elliott MA, Litzow MR, Hogan WJ, Shah MV, Patnaik MM, Pardanani A, Chen D, Reichard KK, He R, Gangat N, Tefferi A, Begna KH.   +19 more
europepmc   +1 more source

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer. [PDF]

Nat Commun
Túrós D, Decollogny M, Moyseos A, Chanfon A, Siffert M, Bousmar J, Romanens L, Tille JC, Tredan O, Labidi-Galy I, Valdeolivas A, Rottenberg S.   +11 more
europepmc   +1 more source

[Minimal residual disease].

Haematologica, 1992
P, Francia di Celle, R, Foà
openaire   +1 more source

Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

JAMA Oncol
Cunningham N, Cutts RJ, Swift C, Coakley M, Sritharan P, Dunne K, Dewan M, Kilburn L, Goddard K, Hall P, Harper-Wynne C, Macpherson IR, Okines A, Wardley A, Waters S, Palmieri C, Winter M, Bliss J, Garcia-Murillas I, Turner NC.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Detection of minimal residual disease

2001
Publisher Summary Minimal residual disease (MRD) is defined as the presence of a small number of cancer cells in hematological malignancies usually below 1010 cells (that amount approximately corresponds to 1g of the total cancer cell burden in a human body).
A, Deptala, S P, Mayer
openaire   +4 more sources

Minimal Residual Disease

Current Opinion in Hematology, 1995
The study of minimal residual disease has been fueled by the technologic advent of the polymerase chain reaction and basic developments identifying the genetic lesions involved in human malignancies. Thus far advances in identifying, cloning, and the subsequent polymerase chain reaction amplification of relevant genes have outpaced clinical studies ...
openaire   +2 more sources

Minimal residual disease

Current Opinion in Hematology, 1998
A major limitation in the treatment of malignant disorders is the accurate and sensitive detection of minimal residual disease. It is clear that routine radiographic and pathologic studies are extremely important, however, lacking in sensitivity. Clearly, the goal of minimal residual disease detection is to make individual treatment decisions such that
openaire   +2 more sources